| 効果 | 減少 |
| 試験方法 | コホート法 |
| 試験期間 | 不明 |
| 被験者数 | 60 |
| 性別 | 不明 |
この研究の注釈：
A comparative study between 50mg of Pueraria and 0.625mg Conjugated Equine Estrogen with 2.5mg MPA noted that both treatments were equally effective in reducing climactic symptoms of menopause over 6 months.
Challenges In The Conduct Of Thai Herbal Scientific Study: Efficacy And Safety Of Phytoestrogen, Pueraria Mirifica (Kwao Keur Kao), Phase I, In The Alleviation Of Climacteric Symptoms In Perimenopausal Women
| 効果 | 減少 |
| 試験方法 | コホート法 |
| 試験期間 | 不明 |
| 被験者数 | 8 |
| 性別 | 不明 |
この研究の注釈：
An open-label study in perimenopausal women noted reductions in menopausal symptoms over 6 months of either 50mg or 100mg Pueraria Mirifica; low sample size
Efficacy And Safety Of Pueraria Mirifica (Kwao Kruea Khao) For The Treatment Of Vasomotor Symptoms In Perimenopausal Women: Phase II Study
| 効果 | 減少 |
| 試験方法 | コホート法 |
| 試験期間 | 不明 |
| 被験者数 | 37 |
| 性別 | 不明 |
この研究の注釈：
50mg and 100mg of supplemental Pueraria Mirifica taken daily for 6 months was associated with a reduction in menopausal symptoms; no control group nor blinding protocol
Comparison Of Pueraria Mirifica 25 And 50 Mg For Menopausal Symptoms
| 効果 | 減少 |
| 試験方法 | コホート法 |
| 試験期間 | 不明 |
| 被験者数 | 52 |
| 性別 | 不明 |
この研究の注釈：
In hysterectomized women (suffering from symptoms of surgery-induced menopause) 25mg and 50mg of Pueraria Mirifica were equally effective in suppressing symptoms of menopause such as hot flases
